"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 4 | 0 | 4 |
| 1999 | 3 | 2 | 5 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 5 | 0 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 6 | 3 | 9 |
| 2005 | 4 | 1 | 5 |
| 2006 | 4 | 2 | 6 |
| 2007 | 4 | 0 | 4 |
| 2008 | 6 | 2 | 8 |
| 2009 | 6 | 2 | 8 |
| 2010 | 7 | 2 | 9 |
| 2011 | 7 | 3 | 10 |
| 2012 | 6 | 0 | 6 |
| 2013 | 8 | 1 | 9 |
| 2014 | 8 | 2 | 10 |
| 2015 | 16 | 1 | 17 |
| 2016 | 18 | 1 | 19 |
| 2017 | 17 | 3 | 20 |
| 2018 | 10 | 3 | 13 |
| 2019 | 12 | 1 | 13 |
| 2020 | 17 | 0 | 17 |
| 2021 | 20 | 2 | 22 |
| 2022 | 10 | 1 | 11 |
| 2023 | 14 | 0 | 14 |
| 2024 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer. Oncologist. 2024 Dec 06; 29(12):e1762-e1769.
-
Empathic communication skills training to reduce lung cancer stigma: Study protocol of a cluster randomized control trial. Contemp Clin Trials. 2024 Oct; 145:107669.
-
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer. Nat Rev Clin Oncol. 2024 Aug; 21(8):610-627.
-
VER-Net: a hybrid transfer learning model for lung cancer detection using CT scan images. BMC Med Imaging. 2024 May 24; 24(1):120.
-
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment. Cancer Lett. 2024 Jun 28; 592:216932.
-
Neurosurgical Management of Spinal Epithelioid Hemangioendothelioma: Systematic Review and Illustrative Case Presentation. World Neurosurg. 2024 Aug; 188:99-110.
-
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2024 Feb; 8:e2300371.
-
Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review. Cancer Invest. 2023 Sep; 41(8):739-749.
-
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. J Neurooncol. 2023 Oct; 165(1):63-77.
-
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer. 2023 10; 11(10).